Brief: Infinity Pharmaceuticals Provides COVID-19 Update
07/04/2020 12:43
April 7 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS PROVIDES UPDATE IN RESPONSE TO
COVID-19
PANDEMIC
* INFINITY PHARMACEUTICALS INC - HAVE NOT YET DETERMINED
ULTIMATE
IMPACT OF COVID-19 ON TRIALS AND FINANCIAL GUIDANCE
* INFINITY PHARMACEUTICALS INC - NOT EXPERIENCED, AND DOES
NOT
ANTICIPATE, ANY DISRUPTION TO DRUG SUPPLY FOR ITS ONGOING
CLINICAL TRIALS
* INFINITY PHARMACEUTICALS INC - CONTINUES TO EVALUATE
IMPACT OF
COVID-19 ON ITS ONGOING CLINICAL AND BUSINESS OPERATIONS
* INFINITY PHARMACEUTICALS INC - ANTICIPATES POTENTIAL
DELAYS IN
TRIAL ENROLLMENT AND SITE INITIATION THAT MAY LEAD TO SHIFTS IN
TIMING OF DATA READOUTS
Source text for Eikon: ID:nBw6ywmSKa
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX